Amundi increased its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 12.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 551,047 shares of the semiconductor company's stock after buying an additional 61,796 shares during the period. Amundi owned 1.72% of Axcelis Technologies worth $27,371,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Fifth Third Bancorp boosted its holdings in Axcelis Technologies by 160.5% in the 1st quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company's stock worth $29,000 after buying an additional 358 shares during the period. Versant Capital Management Inc lifted its stake in Axcelis Technologies by 118.7% in the 1st quarter. Versant Capital Management Inc now owns 584 shares of the semiconductor company's stock worth $29,000 after purchasing an additional 317 shares in the last quarter. Bayforest Capital Ltd purchased a new stake in Axcelis Technologies in the 1st quarter worth approximately $38,000. Nisa Investment Advisors LLC lifted its stake in Axcelis Technologies by 97.5% in the 1st quarter. Nisa Investment Advisors LLC now owns 796 shares of the semiconductor company's stock worth $40,000 after purchasing an additional 393 shares in the last quarter. Finally, Sound Income Strategies LLC purchased a new stake in Axcelis Technologies in the 1st quarter worth approximately $44,000. 89.98% of the stock is owned by institutional investors.
Analyst Ratings Changes
ACLS has been the topic of several recent analyst reports. DA Davidson increased their target price on shares of Axcelis Technologies from $75.00 to $90.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. B. Riley increased their target price on shares of Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 18th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $90.00.
Read Our Latest Report on ACLS
Axcelis Technologies Price Performance
Shares of Axcelis Technologies stock traded up $3.72 on Thursday, hitting $87.00. 347,645 shares of the company traded hands, compared to its average volume of 614,446. The company has a market cap of $2.73 billion, a P/E ratio of 17.78 and a beta of 1.73. Axcelis Technologies, Inc. has a 12-month low of $40.40 and a 12-month high of $110.17. The company has a current ratio of 6.01, a quick ratio of 4.26 and a debt-to-equity ratio of 0.04. The firm's 50-day simple moving average is $76.87 and its 200 day simple moving average is $63.95.
Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.40. The business had revenue of $194.54 million for the quarter, compared to analyst estimates of $185.15 million. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. The company's revenue was down 24.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.55 EPS. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. Analysts expect that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.
Axcelis Technologies Profile
(
Free Report)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Recommended Stories

Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.